Capripoxvirus-vectored vaccines against livestock diseases in Africa

Antiviral Research

Volumn 98, Issue 2, 2013, Pages 217-227

  Boshra, Hani ^a   Truong, Thang ^a   Nfon, Charles ^a   Gerdts, Volker ^b   Tikoo, Suresh ^b,c   Babiuk, Lorne A ^d   Kara, Pravesh ^e   Mather, Arshad ^e   Wallace, David ^e,f   Babiuk, Shawn ^a,g  

^a CANADIAN FOOD INSPECTION AGENCY   (Canada)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

^c UNIVERSITY OF SASKATCHEWAN   (Canada)

^d UNIVERSITY OF ALBERTA   (Canada)

^e ONDERSTEPOORT VETERINARY INSTITUTE   (South Africa)

^f UNIVERSITY OF PRETORIA   (South Africa)

^g UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Capripoxvirus; Goat pox; Goat pox.; Lumpy skin disease; Peste des petits ruminants; Rift Valley fever; Sheep pox

Indexed keywords

ARASUR 87 VACCINE; AV41 VACCINE; CLONE 13 VACCINE; COIMBATORE 97; GORGAN VACCINE; INACTIVATED VIRULENT RVFV VACCINE; KS 1 VACCINE; MYSORE VACCINE; NIGERIAN 71 VACCINE; NIGERIAN 75 VACCINE; O240 VACCINE; ONDERSTEPOORT VACCINE; RECOMBINANT VACCINE; RM 65 VACCINE; ROMANIAN VACCINE; SMITHBURN VACCINE; SUNGRI 96 VACCINE; UNCLASSIFIED DRUG; VIRUS VACCINE; VIRUS VECTOR;

AFRICA; AGRICULTURAL WORKER; BLUETONGUE; BLUETONGUE ORBIVIRUS; BOVIDS; CAPRIPOXVIRUS; CATTLE PLAGUE VIRUS; DEVELOPING COUNTRY; GOATPOX; IMMUNOGENICITY; LIVESTOCK; LUMPY SKIN DISEASE; MEASLES VIRUS; NONHUMAN; PESTE DES PETITS RUMINANTS; PRIORITY JOURNAL; PUBLIC HEALTH PROBLEM; REVIEW; RIFT VALLEY FEVER; RIFT VALLEY FEVER BUNYAVIRUS; RINDERPEST; SHEEPPOX; VACCINATION; VACCINIA VIRUS; VIRUS CLASSIFICATION; VIRUS INFECTION; VIRUS RECOMBINANT;

CAPRA HIRCUS; CAPRIPOXVIRUS; OVIS ARIES; PESTE-DES-PETITS-RUMINANTS VIRUS;

EID: 84876006438     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2013.02.016     Document Type: Review

References (189)

1. Adam, A.A., Karsany, M.S., Adam, I., 2010. Manifestations of severe Rift Valley fever in Sudan. Int. J. Infect. Dis. 14, e179-e180. http://dx.doi.org/10.1016/j.ijid.2009.03.029, pii: S1201-9712(09)00185-4.
2. Adam A.A., Karsany M.S., Adam I. Manifestations of severe Rift Valley fever in Sudan. Int. J. Infect. Dis. 2010, 14:e179-e180. pii: S1201-9712(09)00185-4. 10.1016/j.ijid.2009.03.029.
3. African Union International Bureau for Animal Resources, 2012. Impact of livestock diseases in Africa. May.
4. African Union International Bureau for Animal Resources, 2012. Impact of livestock diseases in Africa. May.
5. Aspden, K., van Dijk, A.A., Bingham, J., Cox, D., Passmore, J.A., Williamson, A.L., 2002. Immunogenicity of a recombinant lumpy skin disease virus (neethling vaccine strain) expressing the rabies virus glycoprotein in cattle. Vaccine 20, 2693- 2701.
6. Aspden K., van Dijk A.A., Bingham J., Cox D., Passmore J.A., Williamson A.L. Immunogenicity of a recombinant lumpy skin disease virus (neethling vaccine strain) expressing the rabies virus glycoprotein in cattle. Vaccine 2002, 20:2693-2701.
7. Ayalet, G., Abate, Y., Sisay, T., Nigussie, H., Gelaye, E., Jemberie, S., Asmare, K., in press. Lumpy skin disease: preliminary vaccine efficacy assessment and overview on outbreak impact in dairy cattle at Debrezeit, central Ethiopia. Antiviral Res. doi: pii: S0166-3542(13)00044-2. doi:10.1016/j.antiviral.2013.02.008.
8. Ayalet, G., Abate, Y., Sisay, T., Nigussie, H., Gelaye, E., Jemberie, S., Asmare, K., in press. Lumpy skin disease: preliminary vaccine efficacy assessment and overview on outbreak impact in dairy cattle at Debrezeit, central Ethiopia.Antiviral Res. doi: http://dx.doi.org/10.1016/j.antiviral.2013.02.008. pii: S0166- 3542(13)00044-2.
9. Ayari-Fakhfakh E., Zaverucha do Valle T., Guillemot L., Panthier J.J., Bouloy M., Ghram A., Albina E., Cetre-Sossah C. MBT/Pas mouse: a relevant model for the evaluation of Rift Valley fever vaccines. J. Gen. Virol. 2012, 93:1456-1464. 10.1099/vir.0.042754-0.
10. Ayari-Fakhfakh, E., Zaverucha do Valle, T., Guillemot, L., Panthier, J.J., Bouloy, M., Ghram, A., Albina, E., Cetre-Sossah, C., 2012. MBT/Pas mouse: a relevant model for the evaluation of Rift Valley fever vaccines. J. Gen. Virol. 93, 1456-1464. http://dx.doi.org/10.1099/vir.0.042754-0.
11. Babiuk, S., Bowden, T.R., Parkyn, G., Dalman, B., Hoa, D.M., Long, N.T., Vu, P.P., Bieu do, X., Copps, J., Boyle, D.B., 2009. Yemen and Vietnam capripoxviruses demonstrate a distinct host preference for goats compared with sheep. J. Gen. Virol. 90, 105-114. http://dx.doi.org/10.1099/vir.0.004507-0.
12. Babiuk S., Bowden T.R., Parkyn G., Dalman B., Hoa D.M., Long N.T., Vu P.P., Bieu do X., Copps J., Boyle D.B. Yemen and Vietnam capripoxviruses demonstrate a distinct host preference for goats compared with sheep. J. Gen. Virol. 2009, 90:105-114. 10.1099/vir.0.004507-0.
13. Babiuk S., Bowden T.R., Boyle D.B., Wallace D.B., Kitching R.P. Capripoxviruses: an emerging worldwide threat to sheep, goats and cattle. Transbound Emerg. Dis. 2008, 55:263-272. 10.1111/j.1865-1682.2008.01043.x.
14. Babiuk, S., Bowden, T.R., Boyle, D.B., Wallace, D.B., Kitching, R.P., 2008. Capripoxviruses: an emerging worldwide threat to sheep, goats and cattle. Transbound Emerg. Dis. 55, 263-272. http://dx.doi.org/10.1111/j.1865- 1682.2008.01043.x.
15. Bailey, D., Banyard, A., Dash, P., Ozkul, A., Barrett, T., 2005. Full genome sequence of peste des petits ruminants virus, a member of the Morbillivirus genus. Virus Res. 110, 119-124. http://dx.doi.org/10.1016/j.virusres.2005.01.013.
16. Bailey D., Banyard A., Dash P., Ozkul A., Barrett T. Full genome sequence of peste des petits ruminants virus, a member of the Morbillivirus genus. Virus Res. 2005, 110:119-124. 10.1016/j.virusres.2005.01.013.
17. Baron M.D., Parida S., Oura C.A. Peste des petits ruminants: a suitable candidate for eradication?. Vet. Rec. 2011, 169:16-21. 10.1136/vr.d3947.
18. Baron, M.D., Parida, S., Oura, C.A., 2011. Peste des petits ruminants: a suitable candidate for eradication Vet. Rec. 169, 16-21. http://dx.doi.org/10.1136/vr.d3947.
19. Bengis, R.G., Swanepoel, R., De Klerk, M., Pienaar, N.J., Prinsloo, G., 2010. Rift Valley fever: current concepts and recent findings. In: Proceedings of the 9th Annual Congress of the South African Society for Veterinary Epidemiology and, Preventive Medicine, pp. 2-12.
20. Bengis, R.G., Swanepoel, R., De Klerk, M., Pienaar, N.J., Prinsloo, G., 2010. Rift Valley fever: current concepts and recent findings. In: Proceedings of the 9th Annual Congress of the South African Society for Veterinary Epidemiology and, Preventive Medicine, pp. 2-12.
21. Berhe, G., Minet, C., Le Goff, C., Barrett, T., Ngangnou, A., Grillet, C., Libeau, G., Fleming, M., Black, D.N., Diallo, A., 2003. Development of a dual recombinant vaccine to protect small ruminants against peste-des-petits-ruminants virus and capripoxvirus infections. J. Virol. 77, 1571-1577.
22. Berhe G., Minet C., Le Goff C., Barrett T., Ngangnou A., Grillet C., Libeau G., Fleming M., Black D.N., Diallo A. Development of a dual recombinant vaccine to protect small ruminants against peste-des-petits-ruminants virus and capripoxvirus infections. J. Virol. 2003, 77:1571-1577.
23. Bhanuprakash, V., Indrani, B.K., Hosamani, M., Singh, R.K., 2006. The current status of sheep pox disease. Comp. Immunol. Microbiol. Infect. Dis. 29, 27-60. http://dx.doi.org/10.1016/j.cimid.2005.12.001.
24. Bhanuprakash V., Indrani B.K., Hosamani M., Singh R.K. The current status of sheep pox disease. Comp. Immunol. Microbiol. Infect. Dis. 2006, 29:27-60. 10.1016/j.cimid.2005.12.001.
25. Bhanuprakash, V., Hosamani, M., Singh, R.K., 2011. Prospects of control and eradication of capripox from the Indian subcontinent: a perspective. Antiviral Res. 91, 225-232. http://dx.doi.org/10.1016/j.antiviral.2011.06.004.
26. Bhanuprakash V., Hosamani M., Singh R.K. Prospects of control and eradication of capripox from the Indian subcontinent: a perspective. Antiviral Res. 2011, 91:225-232. 10.1016/j.antiviral.2011.06.004.
27. Blancou, J., Kieny, M.P., Lathe, R., Lecocq, J.P., Pastoret, P.P., Soulebot, J.P., Desmettre, P., 1986. Oral vaccination of the fox against rabies using a live recombinant vaccinia virus. Nature 322, 373-375.
28. Blancou J., Kieny M.P., Lathe R., Lecocq J.P., Pastoret P.P., Soulebot J.P., Desmettre P. Oral vaccination of the fox against rabies using a live recombinant vaccinia virus. Nature 1986, 322:373-375.
29. Boshra, H., Lorenzo, G., Busquets, N., Brun, A., 2011a. Rift valley fever: recent insights into pathogenesis and prevention. J. Virol. 85, 6098-6105. http://dx.doi.org/10.1128/JVI.02641-10.
30. Boshra H., Lorenzo G., Busquets N., Brun A. Rift valley fever: recent insights into pathogenesis and prevention. J. Virol. 2011, 85:6098-6105. 10.1128/JVI.02641-10.
31. Boshra H., Lorenzo G., Rodriguez F., Brun A. A DNA vaccine encoding ubiquitinated Rift Valley fever virus nucleoprotein provides consistent immunity and protects IFNAR(-/-) mice upon lethal virus challenge. Vaccine 2011, 29:4469-4475. 10.1016/j.vaccine.2011.04.043.
32. Boshra, H., Lorenzo, G., Rodriguez, F., Brun, A., 2011b. A DNA vaccine encoding ubiquitinated Rift Valley fever virus nucleoprotein provides consistent immunity and protects IFNAR(/) mice upon lethal virus challenge. Vaccine 29, 4469-4475. http://dx.doi.org/10.1016/j.vaccine.2011.04.043.
33. Botros B., Omar A., Elian K., Mohamed G., Soliman A., Salib A., Salman D., Saad M., Earhart K. Adverse response of non-indigenous cattle of European breeds to live attenuated Smithburn Rift Valley fever vaccine. J. Med. Virol. 2006, 78:787-791. 10.1002/jmv.20624.
34. Botros, B., Omar, A., Elian, K., Mohamed, G., Soliman, A., Salib, A., Salman, D., Saad, M., Earhart, K., 2006. Adverse response of non-indigenous cattle of European breeds to live attenuated Smithburn Rift Valley fever vaccine. J. Med. Virol. 78, 787-791. http://dx.doi.org/10.1002/jmv.20624.
35. Bowden T.R., Babiuk S.L., Parkyn G.R., Copps J.S., Boyle D.B. Capripoxvirus tissue tropism and shedding: a quantitative study in experimentally infected sheep and goats. Virology 2008, 371:380-393. 10.1016/j.virol.2007.10.002.
36. Bowden, T.R., Babiuk, S.L., Parkyn, G.R., Copps, J.S., Boyle, D.B., 2008. Capripoxvirus tissue tropism and shedding: a quantitative study in experimentally infected sheep and goats. Virology 371, 380-393. http://dx.doi.org/10.1016/j.virol.2007.10.002.
37. Centers for Disease Control and Prevention (CDC), 2007. Rift Valley fever outbreak- Kenya, November 2006-January 2007. MMWR Morb. Mortal. Wkly. Rep. 56, 73- 76.
38. Centers for Disease Control and Prevention (CDC) Rift Valley fever outbreak-Kenya, November 2006-January 2007. MMWR Morb. Mortal. Wkly. Rep. 2007, 56:73-76.
39. Chandran, D., Reddy, K.B., Vijayan, S.P., Sugumar, P., Rani, G.S., Kumar, P.S., Rajendra, L., Srinivasan, V.A., 2010. MVA recombinants expressing the fusion and hemagglutinin genes of PPRV protects goats against virulent challenge. Indian J. Microbiol. 50, 266-274. http://dx.doi.org/10.1007/s12088-010-0026-9.
40. Chandran D., Reddy K.B., Vijayan S.P., Sugumar P., Rani G.S., Kumar P.S., Rajendra L., Srinivasan V.A. MVA recombinants expressing the fusion and hemagglutinin genes of PPRV protects goats against virulent challenge. Indian J. Microbiol. 2010, 50:266-274. 10.1007/s12088-010-0026-9.
41. Chen W., Hu S., Qu L., Hu Q., Zhang Q., Zhi H., Huang K., Bu Z. A goat poxvirus-vectored peste-des-petits-ruminants vaccine induces long-lasting neutralization antibody to high levels in goats and sheep. Vaccine 2010, 28:4742-4750. 10.1016/j.vaccine.2010.04.102.
42. Chen, W., Hu, S., Qu, L., Hu, Q., Zhang, Q., Zhi, H., Huang, K., Bu, Z., 2010. A goat poxvirus-vectored peste-des-petits-ruminants vaccine induces long-lasting neutralization antibody to high levels in goats and sheep. Vaccine 28, 4742- 4750. http://dx.doi.org/10.1016/j.vaccine.2010.04.102.
43. Chevalier V., Pepin M., Plee L., Lancelot R. Rift Valley fever-a threat for Europe?. Euro. Surveill. 2010, 15:19506.
44. Chevalier, V., Pepin, M., Plee, L., Lancelot, R., 2010. Rift Valley fever-a threat for Europe Euro. Surveill. 15, 19506.
45. Chihota, C.M., Rennie, L.F., Kitching, R.P., Mellor, P.S., 2001. Mechanical transmission of lumpy skin disease virus by Aedes aegypti (Diptera: Culicidae). Epidemiol. Infect. 126, 317-321.
46. Chihota C.M., Rennie L.F., Kitching R.P., Mellor P.S. Mechanical transmission of lumpy skin disease virus by Aedes aegypti (Diptera: Culicidae). Epidemiol. Infect. 2001, 126:317-321.
47. Cohen, A., Cox, D., van Dijk, A.A., Korber, A., Dumbell, K.R., Williamson, A., 1997. Lumpy skin disease virus as a recombinant vaccine vector for Rift Valley fever virus and bovine ephemeral fever virus. In: Proceedings of the 4th Congress of the European Society for Veterinary Virology, Edinburgh, Scotland, 24-27 August, pp. 230-231.
48. Cohen, A., Cox, D., van Dijk, A.A., Korber, A., Dumbell, K.R., Williamson, A., 1997. Lumpy skin disease virus as a recombinant vaccine vector for Rift Valley fever virus and bovine ephemeral fever virus. In: Proceedings of the 4th Congress of the European Society for Veterinary Virology, Edinburgh, Scotland, 24-27 August, pp. 230-231.
49. Davies, F.G., Mbugwa, G., 1985. The alterations in pathogenicity and immunogenicity of a Kenya sheep and goat pox virus on serial passage in bovine foetal muscle cell cultures. J. Comp. Pathol. 95, 565-572.
50. Davies F.G., Mbugwa G. The alterations in pathogenicity and immunogenicity of a Kenya sheep and goat pox virus on serial passage in bovine foetal muscle cell cultures. J. Comp. Pathol. 1985, 95:565-572.
51. de Boer, S.M., Kortekaas, J., Antonis, A.F., Kant, J., van Oploo, J.L., Rottier, P.J., Moormann, R.J., Bosch, B.J., 2010. Rift Valley fever virus subunit vaccines confer complete protection against a lethal virus challenge. Vaccine 28, 2330-2339. http://dx.doi.org/10.1016/j.vaccine.2009.12.062, pii: S0264-410X(09)01979-3.
52. de Boer S.M., Kortekaas J., Antonis A.F., Kant J., van Oploo J.L., Rottier P.J., Moormann R.J., Bosch B.J. Rift Valley fever virus subunit vaccines confer complete protection against a lethal virus challenge. Vaccine 2010, 28:2330-2339. pii: S0264-410X(09)01979-3. 10.1016/j.vaccine.2009.12.062.
53. Diallo A., Taylor W.P., Lefevre P.C., Provost A. Attenuation of a strain of rinderpest virus: potential homologous live vaccine. Rev. Elev. Med. Vet. Pays. Trop. 1989, 42:311-319.
54. Diallo, A., Taylor, W.P., Lefevre, P.C., Provost, A., 1989. Attenuation of a strain of rinderpest virus: potential homologous live vaccine. Rev. Elev. Med. Vet. Pays. Trop. 42, 311-319.
55. Diallo, A., Minet, C., Berhe, G., Le Goff, C., Black, D.N., Fleming, M., Barrett, T., Grillet, C., Libeau, G., 2002. Goat immune response to capripox vaccine expressing the hemagglutinin protein of peste des petits ruminants. Ann. NY Acad. Sci. 969, 88-91.
56. Diallo A., Minet C., Berhe G., Le Goff C., Black D.N., Fleming M., Barrett T., Grillet C., Libeau G. Goat immune response to capripox vaccine expressing the hemagglutinin protein of peste des petits ruminants. Ann. NY Acad. Sci. 2002, 969:88-91.
57. Diallo A. Control of peste des petits ruminants: classical and new generation vaccines. Dev. Biol. (Basel) 2003, 114:113-119.
58. Diallo, A., 2003. Control of peste des petits ruminants: classical and new generation vaccines. Dev. Biol. (Basel) 114, 113-119.
59. Diallo A. Vaccination for the control of peste des petits ruminants. Dev. Biol. (Basel) 2004, 119:93-98.
60. Diallo, A., 2004. Vaccination for the control of peste des petits ruminants. Dev. Biol. (Basel) 119, 93-98.
61. Diallo, A., Minet, C., Le Goff, C., Berhe, G., Albina, E., Libeau, G., Barrett, T., 2007. The threat of peste des petits ruminants: progress in vaccine development for disease control. Vaccine 25, 5591-5597. http://dx.doi.org/10.1016/j.vaccine.2007.02.013.
62. Diallo A., Minet C., Le Goff C., Berhe G., Albina E., Libeau G., Barrett T. The threat of peste des petits ruminants: progress in vaccine development for disease control. Vaccine 2007, 25:5591-5597. 10.1016/j.vaccine.2007.02.013.
63. Dungu B., Louw I., Lubisi A., Hunter P., von Teichman B.F., Bouloy M. Evaluation of the efficacy and safety of the Rift Valley fever clone 13 vaccine in sheep. Vaccine 2010, 28:4581-4587. pii: S0264-410X(10)00621-3. 10.1016/j.vaccine.2010.04.085.
64. Dungu, B., Louw, I., Lubisi, A., Hunter, P., von Teichman, B.F., Bouloy, M., 2010. Evaluation of the efficacy and safety of the Rift Valley fever clone 13 vaccine in sheep. Vaccine 28, 4581-4587. http://dx.doi.org/10.1016/j.vaccine.2010.04.085, pii: S0264-410X(10)00621-3.
65. El Hag Ali B., Taylor W.P. Isolation of peste des petits ruminants virus from the Sudan. Res. Vet. Sci. 1984, 36:1-4.
66. El Hag Ali, B., Taylor, W.P., 1984. Isolation of peste des petits ruminants virus from the Sudan. Res. Vet. Sci. 36, 1-4.
67. El Mamy, A.B., Baba, M.O., Barry, Y., Isselmou, K., Dia, M.L., El Kory, M.O., Diop, M., Lo, M.M., Thiongane, Y., Bengoumi, M., Puech, L., Plee, L., Claes, F., de La Rocque, S., Doumbia, B.,. Unexpected Rift Valley fever outbreak, northern Mauritania. Emerg. Infect. Dis. 17, 1894-1896. http://dx.doi.org/10.3201/eid1710.110397. FAO, 2010. FAOSTAT-statistical database (Africa).
68. El Mamy A.B., Baba M.O., Barry Y., Isselmou K., Dia M.L., El Kory M.O., Diop M., Lo M.M., Thiongane Y., Bengoumi M., Puech L., Plee L., Claes F., de La Rocque S., Doumbia B. Unexpected Rift Valley fever outbreak, northern Mauritania. Emerg. Infect. Dis. 2011, 17:1894-1896. 10.3201/eid1710.110397.
69. Gargadennec, L., Lalanne, A., 1942. La peste des petits ruminants. Bulletin des Services Zoo Techniques et des Epizzoties de l'Afrique Occidentale Francaise 5, 16-21.
70. FAO, 2010. FAOSTAT-statistical database (Africa).
71. Gibbs, E.P., Taylor, W.P., Lawman, M.J., Bryant, J., 1979. Classification of peste des petits ruminants virus as the fourth member of the genus Morbillivirus. Intervirology 11, 268-274.
72. Gargadennec L., Lalanne A. La peste des petits ruminants. Bulletin des Services Zoo Techniques et des Epizzoties de l'Afrique Occidentale Francaise 1942, 5:16-21.
73. Gorchakov, R., Volkova, E., Yun, N., Petrakova, O., Linde, N.S., Paessler, S., Frolova, E., Frolov, I., 2007. Comparative analysis of the alphavirus-based vectors expressing Rift Valley fever virus glycoproteins. Virology 366, 212-225. http://dx.doi.org/10.1016/j.virol.2007.04.014, pii: S0042-6822(07)00267-X.
74. Gibbs E.P., Taylor W.P., Lawman M.J., Bryant J. Classification of peste des petits ruminants virus as the fourth member of the genus Morbillivirus. Intervirology 1979, 11:268-274.
75. Hartley, D.M., Rinderknecht, J.L., Nipp, T.L., Clarke, N.P., Snowder, G.D., 2011. National Center for Foreign Animal and Zoonotic Disease Defense Advisory Group on Rift Valley Fever, 2011. Potential effects of Rift Valley fever in the United States. Emerg. Infect. Dis. 17, e1. http://dx.doi.org/10.3201/eid1708.101088.
76. Gorchakov R., Volkova E., Yun N., Petrakova O., Linde N.S., Paessler S., Frolova E., Frolov I. Comparative analysis of the alphavirus-based vectors expressing Rift Valley fever virus glycoproteins. Virology 2007, 366:212-225. pii: S0042-6822(07)00267-X. 10.1016/j.virol.2007.04.014.
77. Hartley D.M., Rinderknecht J.L., Nipp T.L., Clarke N.P., Snowder G.D. National Center for Foreign Animal and Zoonotic Disease Defense Advisory Group on Rift Valley Fever, 2011. Potential effects of Rift Valley fever in the United States. Emerg. Infect. Dis. 2011, 17:e1. 10.3201/eid1708.101088.
78. Holman, D.H., Penn-Nicholson, A., Wang, D., Woraratanadharm, J., Harr, M.K., Luo, M., Maher, E.M., Holbrook, M.R., Dong, J.Y., 2009. A complex adenovirusvectored vaccine against Rift Valley fever virus protects mice against lethal infection in the presence of preexisting vector immunity. Clin. Vaccine Immunol. 16, 1624-1632.
79. Holman D.H., Penn-Nicholson A., Wang D., Woraratanadharm J., Harr M.K., Luo M., Maher E.M., Holbrook M.R., Dong J.Y. A complex adenovirus-vectored vaccine against Rift Valley fever virus protects mice against lethal infection in the presence of preexisting vector immunity. Clin. Vaccine Immunol. 2009, 16:1624-1632.
80. Horman, J.T., Shannon, K.V., Simpson, E.M., Burja, T.M., Fey, R.H., Smith, J.J., Phillips, F.B., 2012. Control of terrestrial animal rabies in Anne Arundel County, Maryland, after oral vaccination of raccoons (1998-2007). J. Am. Vet. Med. Assoc. 241, 725-734. http://dx.doi.org/10.2460/javma.241.6.725.
81. Hunter, P., Wallace, D., 2001. Lumpy skin disease in southern Africa: a review of the disease and aspects of control. J. S. Afr. Vet. Assoc. 72, 68-71.
82. Horman J.T., Shannon K.V., Simpson E.M., Burja T.M., Fey R.H., Smith J.J., Phillips F.B. Control of terrestrial animal rabies in Anne Arundel County, Maryland, after oral vaccination of raccoons (1998-2007). J. Am. Vet. Med. Assoc. 2012, 241:725-734. 10.2460/javma.241.6.725.
83. Hunter P., Wallace D. Lumpy skin disease in southern Africa: a review of the disease and aspects of control. J. S. Afr. Vet. Assoc. 2001, 72:68-71.
84. Ikegami, T., 2012. Molecular biology and genetic diversity of Rift Valley fever virus. Antiviral Res. 95, 293-310. http://dx.doi.org/10.1016/j.antiviral.2012.06.001.
85. Ikegami, T., Won, S., Peters, C.J., Makino, S., 2006. Rescue of infectious rift valley fever virus entirely from cDNA, analysis of virus lacking the NSs gene, and expression of a foreign gene. J. Virol. 80, 2933-2940. http://dx.doi.org/10.1128/JVI.80.6.2933-2940.2006.
86. Ikegami T. Molecular biology and genetic diversity of Rift Valley fever virus. Antiviral Res. 2012, 95:293-310. 10.1016/j.antiviral.2012.06.001.
87. Indran, S.V., Ikegami, T., 2012. Novel approaches to develop Rift Valley fever vaccines. Front. Cell. Infect. Microbiol. 2, 131. http://dx.doi.org/10.3389/fcimb.2012.00131.
88. Ikegami T., Won S., Peters C.J., Makino S. Rescue of infectious rift valley fever virus entirely from cDNA, analysis of virus lacking the NSs gene, and expression of a foreign gene. J. Virol. 2006, 80:2933-2940. 10.1128/JVI.80.6.2933-2940.2006.
89. Iranpour, M., Turell, M.J., Lindsay, L.R., 2011. Potential for Canadian mosquitoes to transmit Rift Valley fever virus. J. Am. Mosq. Control Assoc. 27, 363-369.
90. Indran S.V., Ikegami T. Novel approaches to develop Rift Valley fever vaccines. Front. Cell. Infect. Microbiol. 2012, 2:131. 10.3389/fcimb.2012.00131.
91. Joint document by the FAO, OIE, WHO, UNICEF, World Bank and UN System of Influenza Coordination, 14 October 2008. Contributing to one world, one health-a strategic framwork for reducing risks of infectious diseases at the animal-human-ecosystems interface.
92. Iranpour M., Turell M.J., Lindsay L.R. Potential for Canadian mosquitoes to transmit Rift Valley fever virus. J. Am. Mosq. Control Assoc. 2011, 27:363-369.
93. Kakach, L.T., Wasmoen, T.L., Collett, M.S., 1988. Rift Valley fever virus M segment: use of recombinant vaccinia viruses to study Phlebovirus gene expression. J. Virol. 62, 826-833.
94. Joint document by the FAO, OIE, WHO, UNICEF, World Bank and UN System of Influenza Coordination, 14 October 2008. Contributing to one world, one health-a strategic framwork for reducing risks of infectious diseases at the animal-human-ecosystems interface.
95. Kakach L.T., Wasmoen T.L., Collett M.S. Rift Valley fever virus M segment: use of recombinant vaccinia viruses to study Phlebovirus gene expression. J. Virol. 1988, 62:826-833.
96. Kark, J.D., Aynor, Y., Peters, C.J., 1982. A rift Valley fever vaccine trial. I. Side effects and serologic response over a six-month follow-up. Am. J. Epidemiol. 116, 808- 820.
97. Khandelwal, A., Renukaradhya, G.J., Rajasekhar, M., Sita, G.L., Shaila, M.S., 2011. Immune responses to hemagglutinin-neuraminidase protein of peste des petits ruminants virus expressed in transgenic peanut plants in sheep. Vet. Immunol. Immunopathol. 140, 291-296. http://dx.doi.org/10.1016/j.vetimm.2010.12.007.
98. Kark J.D., Aynor Y., Peters C.J. A rift Valley fever vaccine trial. I. Side effects and serologic response over a six-month follow-up. Am. J. Epidemiol. 1982, 116:808-820.
99. Khandelwal A., Renukaradhya G.J., Rajasekhar M., Sita G.L., Shaila M.S. Immune responses to hemagglutinin-neuraminidase protein of peste des petits ruminants virus expressed in transgenic peanut plants in sheep. Vet. Immunol. Immunopathol. 2011, 140:291-296. 10.1016/j.vetimm.2010.12.007.
100. Kitching, R.P., Taylor, W.P., 1985. Clinical and antigenic relationship between isolates of sheep and goat pox viruses. Trop. Anim. Health Prod. 17, 64-74.
101. Kitching R.P., Taylor W.P. Clinical and antigenic relationship between isolates of sheep and goat pox viruses. Trop. Anim. Health Prod. 1985, 17:64-74.
102. Kitching, R.P., 1986. Passive protection of sheep against capripoxvirus. Res. Vet. Sci. 41, 247-250.
103. Kitching R.P. Passive protection of sheep against capripoxvirus. Res. Vet. Sci. 1986, 41:247-250.
104. Kitching, R.P., Hammond, J.M., Taylor, W.P., 1987. A single vaccine for the control of capripox infection in sheep and goats. Res. Vet. Sci. 42, 53-60.
105. Kitching, R.P., Bhat, P.P., Black, D.N., 1989. The characterization of African strains of capripoxvirus. Epidemiol. Infect. 102, 335-343.
106. Kitching R.P., Hammond J.M., Taylor W.P. A single vaccine for the control of capripox infection in sheep and goats. Res. Vet. Sci. 1987, 42:53-60.
107. Kitching, R.P., 2003. Vaccines for lumpy skin disease, sheep pox and goat pox. Dev. Biol. (Basel) 114, 161-167.
108. Kitching R.P., Bhat P.P., Black D.N. The characterization of African strains of capripoxvirus. Epidemiol. Infect. 1989, 102:335-343.
109. Kitching R.P. Vaccines for lumpy skin disease, sheep pox and goat pox. Dev. Biol. (Basel) 2003, 114:161-167.
110. Kortekaas, J., de Boer, S.M., Kant, J., Vloet, R.P., Antonis, A.F., Moormann, R.J., 2010a. Rift Valley fever virus immunity provided by a paramyxovirus vaccine vector. Vaccine 28, 4394-4401. http://dx.doi.org/10.1016/j.vaccine.2010.04.048, pii: S0264-410X(10)00554-2.
111. Kortekaas J., de Boer S.M., Kant J., Vloet R.P., Antonis A.F., Moormann R.J. Rift Valley fever virus immunity provided by a paramyxovirus vaccine vector. Vaccine 2010, 28:4394-4401. pii: S0264-410X(10)00554-2. 10.1016/j.vaccine.2010.04.048.
112. Kortekaas, J., Dekker, A., de Boer, S.M., Weerdmeester, K., Vloet, R.P., de Wit, A.A., Peeters, B.P., Moormann, R.J., 2010b. Intramuscular inoculation of calves with an experimental Newcastle disease virus-based vector vaccine elicits neutralizing antibodies against Rift Valley fever virus. Vaccine 28, 2271-2276. http://dx.doi.org/10.1016/j.vaccine.2010.01.001, pii: S0264-410X(10)00031-9.
113. Kortekaas J., Dekker A., de Boer S.M., Weerdmeester K., Vloet R.P., de Wit A.A., Peeters B.P., Moormann R.J. Intramuscular inoculation of calves with an experimental Newcastle disease virus-based vector vaccine elicits neutralizing antibodies against Rift Valley fever virus. Vaccine 2010, 28:2271-2276. pii: S0264-410X(10)00031-9. 10.1016/j.vaccine.2010.01.001.
114. Lagerqvist, N., Naslund, J., Lundkvist, A., Bouloy, M., Ahlm, C., Bucht, G., 2009. Characterisation of immune responses and protective efficacy in mice after immunisation with Rift Valley fever virus cDNA constructs. Virol. J. 6, 6. http://dx.doi.org/10.1186/1743-422X-6-6, pii: 1743-422X-6-6.
115. Lorenzo, G., Martin-Folgar, R., Hevia, E., Boshra, H., Brun, A., 2010. Protection against lethal Rift Valley fever virus (RVFV) infection in transgenic IFNAR mice induced by different DNA vaccination regimens. Vaccine 28, 2937-2944. http://dx.doi.org/10.1016/j.vaccine.2010.02.018, pii: S0264-410X(10)00186-6.
116. Lagerqvist N., Naslund J., Lundkvist A., Bouloy M., Ahlm C., Bucht G. Characterisation of immune responses and protective efficacy in mice after immunisation with Rift Valley fever virus cDNA constructs. Virol. J. 2009, 6:6. pii: 1743-422X-6-6. 10.1186/1743-422X-6-6.
117. Mackett, M., Smith, G.L., Moss, B., 1982. Vaccinia virus: a selectable eukaryotic cloning and expression vector. Proc. Natl. Acad. Sci. USA 79, 7415-7419.
118. Lorenzo G., Martin-Folgar R., Hevia E., Boshra H., Brun A. Protection against lethal Rift Valley fever virus (RVFV) infection in transgenic IFNAR(-/-) mice induced by different DNA vaccination regimens. Vaccine 2010, 28:2937-2944. pii: S0264-410X(10)00186-6. 10.1016/j.vaccine.2010.02.018.
119. Mackett M., Smith G.L., Moss B. Vaccinia virus: a selectable eukaryotic cloning and expression vector. Proc. Natl. Acad. Sci. USA 1982, 79:7415-7419.
120. Malik, Y.S., Singh, D., Chandrashekar, K.M., Shukla, S., Sharma, K., Vaid, N., Chakravarti, S., 2011. Occurrence of dual infection of peste-des-petitsruminants and goatpox in indigenous goats of central India. Transbound. Emerg. Dis. 58, 268-273. http://dx.doi.org/10.1111/j.1865-1682.2011.01201.x.
121. McPeak, J., Little, P.I., Doss, C., 2010. Livelihoods in a Risky Environment: Development and Change among East African Pastoralists. Routledge Press, London.
122. Malik Y.S., Singh D., Chandrashekar K.M., Shukla S., Sharma K., Vaid N., Chakravarti S. Occurrence of dual infection of peste-des-petits-ruminants and goatpox in indigenous goats of central India. Transbound. Emerg. Dis. 2011, 58:268-273. 10.1111/j.1865-1682.2011.01201.x.
123. McPeak J., Little P.I., Doss C. Livelihoods in a Risky Environment: Development and Change among East African Pastoralists 2010, Routledge Press, London.
124. Meadors 3rd, G.F., Gibbs, P.H., Peters, C.J., 1986. Evaluation of a new Rift Valley fever vaccine: safety and immunogenicity trials. Vaccine 4, 179-184.
125. Meadors G.F., Gibbs P.H., Peters C.J. Evaluation of a new Rift Valley fever vaccine: safety and immunogenicity trials. Vaccine 1986, 4:179-184.
126. Morrill, J.C., Mebus, C.A., Peters, C.J., 1997a. Safety and efficacy of a mutagenattenuated Rift Valley fever virus vaccine in cattle. Am. J. Vet. Res. 58, 1104-1109.
127. Morrill, J.C., Mebus, C.A., Peters, C.J., 1997b. Safety of a mutagen-attenuated Rift Valley fever virus vaccine in fetal and neonatal bovids. Am. J. Vet. Res. 58, 1110-1114.
128. Morrill J.C., Mebus C.A., Peters C.J. Safety and efficacy of a mutagen-attenuated Rift Valley fever virus vaccine in cattle. Am. J. Vet. Res. 1997, 58:1104-1109.
129. Ngichabe, C.K., Wamwayi, H.M., Ndungu, E.K., Mirangi, P.K., Bostock, C.J., Black, D.N., Barrett, T., 2002. Long term immunity in African cattle vaccinated with a recombinant capripox-rinderpest virus vaccine. Epidemiol. Infect. 128, 343-349.
130. Morrill J.C., Mebus C.A., Peters C.J. Safety of a mutagen-attenuated Rift Valley fever virus vaccine in fetal and neonatal bovids. Am. J. Vet. Res. 1997, 58:1110-1114.
131. OIE, 2010. Sheep and goat pox. In: OIE Terrestrial Manual, p. 2.7.14.
132. Ngichabe C.K., Wamwayi H.M., Ndungu E.K., Mirangi P.K., Bostock C.J., Black D.N., Barrett T. Long term immunity in African cattle vaccinated with a recombinant capripox-rinderpest virus vaccine. Epidemiol. Infect. 2002, 128:343-349.
133. OIE Sheep and goat pox. OIE Terrestrial Manual 2010, 2.7.14.
134. Perrin, A., Albina, E., Breard, E., Sailleau, C., Prome, S., Grillet, C., Kwiatek, O., Russo, P., Thiery, R., Zientara, S., Cetre-Sossah, C., 2007. Recombinant capripoxviruses expressing proteins of bluetongue virus: evaluation of immune responses and protection in small ruminants. Vaccine 25, 6774-6783. http://dx.doi.org/10.1016/j.vaccine.2007.06.052.
135. Perrin A., Albina E., Breard E., Sailleau C., Prome S., Grillet C., Kwiatek O., Russo P., Thiery R., Zientara S., Cetre-Sossah C. Recombinant capripoxviruses expressing proteins of bluetongue virus: evaluation of immune responses and protection in small ruminants. Vaccine 2007, 25:6774-6783. 10.1016/j.vaccine.2007.06.052.
136. Pittman, P.R., Liu, C.T., Cannon, T.L., Makuch, R.S., Mangiafico, J.A., Gibbs, P.H., Peters, C.J., 1999. Immunogenicity of an inactivated Rift Valley fever vaccine in humans: a 12-year experience. Vaccine 18, 181-189.
137. Pittman P.R., Liu C.T., Cannon T.L., Makuch R.S., Mangiafico J.A., Gibbs P.H., Peters C.J. Immunogenicity of an inactivated Rift Valley fever vaccine in humans: a 12-year experience. Vaccine 1999, 18:181-189.
138. Poon, L.L., Leung, Y.H., Nicholls, J.M., Perera, P.Y., Lichy, J.H., Yamamoto, M., Waldmann, T.A., Peiris, J.S., Perera, L.P., 2009. Vaccinia virus-based multivalent H5N1 avian influenza vaccines adjuvanted with IL-15 confer sterile cross-clade protection in mice. J. Immunol. 182, 3063-3071. http://dx.doi.org/10.4049/jimmunol.0803467.
139. Poon L.L., Leung Y.H., Nicholls J.M., Perera P.Y., Lichy J.H., Yamamoto M., Waldmann T.A., Peiris J.S., Perera L.P. Vaccinia virus-based multivalent H5N1 avian influenza vaccines adjuvanted with IL-15 confer sterile cross-clade protection in mice. J. Immunol. 2009, 182:3063-3071. 10.4049/jimmunol.0803467.
140. Qin, J., Huang, H., Ruan, Y., Hou, X., Yang, S., Wang, C., Huang, G., Wang, T., Feng, N., Gao, Y., Xia, X., 2012. A novel recombinant peste des petits ruminants-canine adenovirus vaccine elicits long-lasting neutralizing antibody response against PPR in goats. PLoS ONE 7, e37170. http://dx.doi.org/10.1371/journal.pone.0037170.
141. Qin J., Huang H., Ruan Y., Hou X., Yang S., Wang C., Huang G., Wang T., Feng N., Gao Y., Xia X. A novel recombinant peste des petits ruminants-canine adenovirus vaccine elicits long-lasting neutralizing antibody response against PPR in goats. PLoS ONE 2012, 7:e37170. 10.1371/journal.pone.0037170.
142. Roeder, P.L., 2011. Rinderpest: the end of cattle plague. Prev. Vet. Med. 102, 98-106. http://dx.doi.org/10.1016/j.prevetmed.2011.04.004.
143. Roeder P.L. Rinderpest: the end of cattle plague. Prev. Vet. Med. 2011, 102:98-106. 10.1016/j.prevetmed.2011.04.004.
144. Romero, C.H., Barrett, T., Evans, S.A., Kitching, R.P., Gershon, P.D., Bostock, C., Black, D.N., 1993. Single capripoxvirus recombinant vaccine for the protection of cattle against rinderpest and lumpy skin disease. Vaccine 11, 737-742.
145. Romero, C.H., Barrett, T., Chamberlain, R.W., Kitching, R.P., Fleming, M., Black, D.N., 1994a. Recombinant capripoxvirus expressing the hemagglutinin protein gene of rinderpest virus: protection of cattle against rinderpest and lumpy skin disease viruses. Virology 204, 425-429. http://dx.doi.org/10.1006/viro.1994.1548.
146. Romero C.H., Barrett T., Evans S.A., Kitching R.P., Gershon P.D., Bostock C., Black D.N. Single capripoxvirus recombinant vaccine for the protection of cattle against rinderpest and lumpy skin disease. Vaccine 1993, 11:737-742.
147. Romero, C.H., Barrett, T., Kitching, R.P., Carn, V.M., Black, D.N., 1994b. Protection of cattle against rinderpest and lumpy skin disease with a recombinant capripoxvirus expressing the fusion protein gene of rinderpest virus. Vet. Rec. 135, 152-154.
148. Romero C.H., Barrett T., Chamberlain R.W., Kitching R.P., Fleming M., Black D.N. Recombinant capripoxvirus expressing the hemagglutinin protein gene of rinderpest virus: protection of cattle against rinderpest and lumpy skin disease viruses. Virology 1994, 204:425-429. 10.1006/viro.1994.1548.
149. Romero, C.H., Barrett, T., Kitching, R.P., Bostock, C., Black, D.N., 1995. Protection of goats against peste des petits ruminants with recombinant capripoxviruses expressing the fusion and haemagglutinin protein genes of rinderpest virus. Vaccine 13, 36-40.
150. Romero C.H., Barrett T., Kitching R.P., Carn V.M., Black D.N. Protection of cattle against rinderpest and lumpy skin disease with a recombinant capripoxvirus expressing the fusion protein gene of rinderpest virus. Vet. Rec. 1994, 135:152-154.
151. Rziha, H., Henkel, M., Cottone, R., Bauer, B., Auge, U., Gotz, F., Pfaff, E., Rottgen, M., Dehio, C., Buttner, M., 2000. Generation of recombinant parapoxviruses: nonessential genes suitable for insertion and expression of foreign genes. J. Biotechnol. 83, 137-145.
152. Romero C.H., Barrett T., Kitching R.P., Bostock C., Black D.N. Protection of goats against peste des petits ruminants with recombinant capripoxviruses expressing the fusion and haemagglutinin protein genes of rinderpest virus. Vaccine 1995, 13:36-40.
153. Rziha H., Henkel M., Cottone R., Bauer B., Auge U., Gotz F., Pfaff E., Rottgen M., Dehio C., Buttner M. Generation of recombinant parapoxviruses: non-essential genes suitable for insertion and expression of foreign genes. J. Biotechnol. 2000, 83:137-145.
154. Saravanan, P., Sen, A., Balamurugan, V., Rajak, K.K., Bhanuprakash, V., Palaniswami, K.S., Nachimuthu, K., Thangavelu, A., Dhinakarraj, G., Hegde, R., Singh, R.K., 2010. Comparative efficacy of peste des petits ruminants (PPR) vaccines. Biologicals 38, 479-485. http://dx.doi.org/10.1016/j.biologicals.2010.02.003.
155. Shaila, M.S., Shamaki, D., Forsyth, M.A., Diallo, A., Goatley, L., Kitching, R.P., Barrett, T., 1996. Geographic distribution and epidemiology of peste des petits ruminants virus. Virus Res. 43, 149-153.
156. Saravanan P., Sen A., Balamurugan V., Rajak K.K., Bhanuprakash V., Palaniswami K.S., Nachimuthu K., Thangavelu A., Dhinakarraj G., Hegde R., Singh R.K. Comparative efficacy of peste des petits ruminants (PPR) vaccines. Biologicals 2010, 38:479-485. 10.1016/j.biologicals.2010.02.003.
157. Shen, Y.J., Shephard, E., Douglass, N., Johnston, N., Adams, C., Williamson, C., Williamson, A.L., 2011. A novel candidate HIV vaccine vector based on the replication deficient Capripoxvirus, Lumpy skin disease virus (LSDV). Virol. J. 8, 265. http://dx.doi.org/10.1186/1743-422X-8-265.
158. Shaila M.S., Shamaki D., Forsyth M.A., Diallo A., Goatley L., Kitching R.P., Barrett T. Geographic distribution and epidemiology of peste des petits ruminants virus. Virus Res. 1996, 43:149-153.
159. Shimshony, A., Barzilai, R., 1983. Rift Valley fever. Adv. Vet. Sci. Comp. Med. 27, 347-425.
160. Shen Y.J., Shephard E., Douglass N., Johnston N., Adams C., Williamson C., Williamson A.L. A novel candidate HIV vaccine vector based on the replication deficient Capripoxvirus, Lumpy skin disease virus (LSDV). Virol. J. 2011, 8:265. 10.1186/1743-422X-8-265.
161. Shimshony A., Barzilai R. Rift Valley fever. Adv. Vet. Sci. Comp. Med. 1983, 27:347-425.
162. Silva, A.C., Carrondo, M.J., Alves, P.M., 2011. Strategies for improved stability of peste des petits ruminants vaccine. Vaccine 29, 4983-4991. http://dx.doi.org/10.1016/j.vaccine.2011.04.102.
163. Smithburn, K.C., 1949. Rift Valley fever; the neurotropic adaptation of the virus and the experimental use of this modified virus as a vaccine. Br. J. Exp. Pathol. 30, 1-16.
164. Silva A.C., Carrondo M.J., Alves P.M. Strategies for improved stability of peste des petits ruminants vaccine. Vaccine 2011, 29:4983-4991. 10.1016/j.vaccine.2011.04.102.
165. Smithburn K.C. Rift Valley fever; the neurotropic adaptation of the virus and the experimental use of this modified virus as a vaccine. Br. J. Exp. Pathol. 1949, 30:1-16.
166. Soi, R.K., Rurangirwa, F.R., McGuire, T.C., Rwambo, P.M., DeMartini, J.C., Crawford, T.B., 2010. Protection of sheep against Rift Valley fever virus and sheep poxvirus with a recombinant capripoxvirus vaccine. Clin. Vaccine Immunol. 17, 1842-1849.
167. Soi R.K., Rurangirwa F.R., McGuire T.C., Rwambo P.M., DeMartini J.C., Crawford T.B. Protection of sheep against Rift Valley fever virus and sheep poxvirus with a recombinant capripoxvirus vaccine. Clin. Vaccine Immunol. 2010, 17:1842-1849.
168. Spik, K., Shurtleff, A., McElroy, A.K., Guttieri, M.C., Hooper, J.W., SchmalJohn, C., 2006. Immunogenicity of combination DNA vaccines for Rift Valley fever virus, tick-borne encephalitis virus, Hantaan virus, and Crimean Congo hemorrhagic fever virus. Vaccine 24, 4657-4666. http://dx.doi.org/10.1016/j.vaccine.2005.08.034, pii: S0264-410X(05)00842-X.
169. Taylor, W.P., 1979. Protection of goats against peste-des-petits-ruminants with attenuated rinderpest virus. Res. Vet. Sci. 27, 321-324.
170. Spik K., Shurtleff A., McElroy A.K., Guttieri M.C., Hooper J.W., SchmalJohn C. Immunogenicity of combination DNA vaccines for Rift Valley fever virus, tick-borne encephalitis virus, Hantaan virus, and Crimean Congo hemorrhagic fever virus. Vaccine 2006, 24:4657-4666. pii: S0264-410X(05)00842-X. 10.1016/j.vaccine.2005.08.034.
171. Tsukiyama, K., Yoshikawa, Y., Kamata, H., Imaoka, K., Asano, K., Funahashi, S., Maruyama, T., Shida, H., Sugimoto, M., Yamanouchi, K., 1989. Development of heat-stable recombinant rinderpest vaccine. Arch. Virol. 107, 225-235.
172. Taylor W.P. Protection of goats against peste-des-petits-ruminants with attenuated rinderpest virus. Res. Vet. Sci. 1979, 27:321-324.
173. Tulman, E.R., Afonso, C.L., Lu, Z., Zsak, L., Kutish, G.F., Rock, D.L., 2001. Genome of lumpy skin disease virus. J. Virol. 75, 7122-7130. http://dx.doi.org/10.1128/JVI.75.15.7122-7130.2001.
174. Tsukiyama K., Yoshikawa Y., Kamata H., Imaoka K., Asano K., Funahashi S., Maruyama T., Shida H., Sugimoto M., Yamanouchi K. Development of heat-stable recombinant rinderpest vaccine. Arch. Virol. 1989, 107:225-235.
175. Tulman, E.R., Afonso, C.L., Lu, Z., Zsak, L., Sur, J.H., Sandybaev, N.T., Kerembekova, U.Z., Zaitsev, V.L., Kutish, G.F., Rock, D.L., 2002. The genomes of sheeppox and goatpox viruses. J. Virol. 76, 6054-6061.
176. Tulman E.R., Afonso C.L., Lu Z., Zsak L., Kutish G.F., Rock D.L. Genome of lumpy skin disease virus. J. Virol. 2001, 75:7122-7130. 10.1128/JVI.75.15.7122-7130.2001.
177. Tulman E.R., Afonso C.L., Lu Z., Zsak L., Sur J.H., Sandybaev N.T., Kerembekova U.Z., Zaitsev V.L., Kutish G.F., Rock D.L. The genomes of sheeppox and goatpox viruses. J. Virol. 2002, 76:6054-6061.
178. Wade-Evans, A.M., Romero, C.H., Mellor, P., Takamatsu, H., Anderson, J., Thevasagayam, J., Fleming, M.J., Mertens, P.P., Black, D.N., 1996. Expression of the major core structural protein (VP7) of bluetongue virus, by a recombinant capripox virus, provides partial protection of sheep against a virulent heterotypic bluetongue virus challenge. Virology 220, 227-231. http://dx.doi.org/10.1006/viro.1996.0306.
179. Wallace, D.B., Ellis, C.E., Espach, A., Smith, S.J., Greyling, R.R., Viljoen, G.J., 2006. Protective immune responses induced by different recombinant vaccine regimes to Rift Valley fever. Vaccine 24, 7181-7189. http://dx.doi.org/10.1016/j.vaccine.2006.06.041, pii: S0264-410X(06)00769-9.
180. Wade-Evans A.M., Romero C.H., Mellor P., Takamatsu H., Anderson J., Thevasagayam J., Fleming M.J., Mertens P.P., Black D.N. Expression of the major core structural protein (VP7) of bluetongue virus, by a recombinant capripox virus, provides partial protection of sheep against a virulent heterotypic bluetongue virus challenge. Virology 1996, 220:227-231. 10.1006/viro.1996.0306.
181. Wallace, D.B., Weyer, J., Nel, L.H., Viljoen, G.J., 2007. Improved method for the generation and selection of homogeneous lumpy skin disease virus (SANeethling) recombinants. J. Virol. Methods 146, 52-60. http://dx.doi.org/10.1016/j.jviromet.2007.06.004.
182. Wallace D.B., Ellis C.E., Espach A., Smith S.J., Greyling R.R., Viljoen G.J. Protective immune responses induced by different recombinant vaccine regimes to Rift Valley fever. Vaccine 2006, 24:7181-7189. pii: S0264-410X(06)00769-9. 10.1016/j.vaccine.2006.06.041.
183. Wang, Z., Bao, J., Wu, X., Liu, Y., Li, L., Liu, C., Suo, L., Xie, Z., Zhao, W., Zhang, W., Yang, N., Li, J., Wang, S., Wang, J., 2009. Peste des petits ruminants virus in Tibet. China. Emerg. Infect. Dis. 15, 299-301.
184. Wallace D.B., Weyer J., Nel L.H., Viljoen G.J. Improved method for the generation and selection of homogeneous lumpy skin disease virus (SA-Neethling) recombinants. J. Virol. Methods 2007, 146:52-60. 10.1016/j.jviromet.2007.06.004.
185. Wang Z., Bao J., Wu X., Liu Y., Li L., Liu C., Suo L., Xie Z., Zhao W., Zhang W., Yang N., Li J., Wang S., Wang J. Peste des petits ruminants virus in Tibet. China. Emerg. Infect. Dis. 2009, 15:299-301.
186. World Bank, 2011. Fact Sheet: The World Bank and Africa.
187. World Bank, 2011. Fact Sheet: The World Bank and Africa.
188. Yeruham, I., Perl, S., Nyska, A., Abraham, A., Davidson, M., Haymovitch, M., Zamir, O., Grinstein, H., 1994. Adverse reactions in cattle to a capripox vaccine. Vet. Rec. 135, 330-332.
189. Yeruham I., Perl S., Nyska A., Abraham A., Davidson M., Haymovitch M., Zamir O., Grinstein H. Adverse reactions in cattle to a capripox vaccine. Vet. Rec. 1994, 135:330-332.